{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:23:56Z","timestamp":1776119036893,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Foundation for Science and Technology (FCT) funded the MARVEL project","award":["PTDC\/SAU-PUB\/4018\/2021"],"award-info":[{"award-number":["PTDC\/SAU-PUB\/4018\/2021"]}]},{"name":"Foundation for Science and Technology (FCT) funded the MARVEL project","award":["PTDC\/SAU-PUB\/4018\/2021"],"award-info":[{"award-number":["PTDC\/SAU-PUB\/4018\/2021"]}]},{"name":"Foundation for Science and Technology (FCT) funded the MARVEL project","award":["PTDC\/SAU-PUB\/4018\/2021"],"award-info":[{"award-number":["PTDC\/SAU-PUB\/4018\/2021"]}]},{"name":"Foundation for Science and Technology (FCT) funded the MARVEL project","award":["PTDC\/SAU-PUB\/4018\/2021"],"award-info":[{"award-number":["PTDC\/SAU-PUB\/4018\/2021"]}]},{"name":"Foundation for Science and Technology (FCT) funded the MARVEL project","award":["PTDC\/SAU-PUB\/4018\/2021"],"award-info":[{"award-number":["PTDC\/SAU-PUB\/4018\/2021"]}]},{"name":"Calouste Gulbenkian Foundation (FCG), HITOLA project","award":["250466"],"award-info":[{"award-number":["250466"]}]},{"name":"GHTM","award":["GHTM-UID\/04413\/2020"],"award-info":[{"award-number":["GHTM-UID\/04413\/2020"]}]},{"name":"GHTM","award":["GHTM-UID\/04413\/2020"],"award-info":[{"award-number":["GHTM-UID\/04413\/2020"]}]},{"name":"GHTM","award":["GHTM-UID\/04413\/2020"],"award-info":[{"award-number":["GHTM-UID\/04413\/2020"]}]},{"name":"GHTM","award":["GHTM-UID\/04413\/2020"],"award-info":[{"award-number":["GHTM-UID\/04413\/2020"]}]},{"name":"GHTM","award":["GHTM-UID\/04413\/2020"],"award-info":[{"award-number":["GHTM-UID\/04413\/2020"]}]},{"name":"LA-REAL","award":["LA\/P\/0117\/2020"],"award-info":[{"award-number":["LA\/P\/0117\/2020"]}]},{"name":"LA-REAL","award":["LA\/P\/0117\/2020"],"award-info":[{"award-number":["LA\/P\/0117\/2020"]}]},{"name":"LA-REAL","award":["LA\/P\/0117\/2020"],"award-info":[{"award-number":["LA\/P\/0117\/2020"]}]},{"name":"LA-REAL","award":["LA\/P\/0117\/2020"],"award-info":[{"award-number":["LA\/P\/0117\/2020"]}]},{"name":"LA-REAL","award":["LA\/P\/0117\/2020"],"award-info":[{"award-number":["LA\/P\/0117\/2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09803-1","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T09:13:13Z","timestamp":1724922793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MARVEL-minimising the emergence and dissemination of HIV-1 drug resistance in Portuguese-speaking African Countries (PALOP): low-cost portable NGS platform for HIV-1 surveillance in Africa"],"prefix":"10.1186","volume":"24","author":[{"given":"Cruz S.","family":"Sebasti\u00e3o","sequence":"first","affiliation":[]},{"given":"Marta","family":"Pingarilho","sequence":"additional","affiliation":[]},{"given":"Jamila","family":"Bathy","sequence":"additional","affiliation":[]},{"given":"Eliz\u00e2ngela","family":"Bonfim","sequence":"additional","affiliation":[]},{"given":"Katia","family":"Toancha","sequence":"additional","affiliation":[]},{"given":"Mafalda N.S.","family":"Miranda","sequence":"additional","affiliation":[]},{"given":"M Ros\u00e1rio O.","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Perpetua","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Lazismino","family":"L\u00e1zaro","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Pina-Araujo","sequence":"additional","affiliation":[]},{"given":"Tacilta","family":"Nhampossa","sequence":"additional","affiliation":[]},{"given":"Silvania","family":"Leal","sequence":"additional","affiliation":[]},{"given":"Ana B.","family":"Abecasis","sequence":"additional","affiliation":[]},{"given":"Victor","family":"Pimentel","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"9803_CR1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMms1513641","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV Epidemic: a plan for the United States. JAMA. 2019. https:\/\/doi.org\/10.1056\/NEJMms1513641.","journal-title":"JAMA"},{"key":"9803_CR2","unstructured":"United Nations. Political Declaration on HIV and AIDS: On the Fast Track to Accelerating the Fight against HIV and to Ending the AIDS Epidemic by 2030. 2016;17020 June:1\u201326."},{"key":"9803_CR3","unstructured":"WHO, HIV drug resistance HIV drug resistance. Report 2021. 2021."},{"key":"9803_CR4","first-page":"3","volume":"17","author":"D Ssemwanga","year":"2015","unstructured":"Ssemwanga D, Lihana RW, Ugoji C, Abimiku A, Nkengasong J, Dakum P, et al. Update on HIV-1 acquired and transmitted drug resistance in Africa. AIDS Rev. 2015;17:3\u201320.","journal-title":"AIDS Rev"},{"key":"9803_CR5","unstructured":"WHO. Clinical Guidelines: Antiretroviral Therapy. WHO. 2016; Second Edition:129."},{"key":"9803_CR6","doi-asserted-by":"publisher","first-page":"e0267159","DOI":"10.1371\/journal.pone.0267159","volume":"17","author":"M Melku","year":"2022","unstructured":"Melku M, Gesesew HA, Ward PR. Magnitude and predictors of HIV-Drug resistance in Africa: a protocol for systematic review and meta-analysis. PLoS ONE. 2022;17:e0267159.","journal-title":"PLoS ONE"},{"key":"9803_CR7","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1007\/s10461-020-02937-8","volume":"24","author":"C Benson","year":"2020","unstructured":"Benson C, Wang X, Dunn KJ, Li N, Mesana L, Lai J, et al. Antiretroviral adherence, Drug Resistance, and the Impact of Social Determinants of Health in HIV-1 patients in the US. AIDS Behav. 2020;24:3562\u201373.","journal-title":"AIDS Behav"},{"key":"9803_CR8","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1097\/QAI.0000000000002168","volume":"82","author":"MA Brault","year":"2019","unstructured":"Brault MA, Spiegelman D, Hargreaves J, Nash D, Vermund SH. Treatment as Prevention: concepts and challenges for reducing HIV incidence. JAIDS J Acquir Immune Defic Syndr. 2019;82:S104\u201312.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"9803_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.2174\/187152612804142251","volume":"12","author":"S Emamzadeh-Fard","year":"2012","unstructured":"Emamzadeh-Fard S, Fard E, SeyedAlinaghi S, Paydary S. Adherence to anti-retroviral therapy and its determinants in HIV\/AIDS patients: a review. Infect Disord Drug Targets. 2012;12:346\u201356.","journal-title":"Infect Disord Drug Targets"},{"key":"9803_CR10","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/infdis\/jix089","volume":"215","author":"AN Phillips","year":"2017","unstructured":"Phillips AN, Stover J, Cambiano V, Nakagawa F, Jordan MR, Pillay D, et al. Impact of HIV Drug Resistance on HIV\/AIDS-Associated Mortality, New Infections, and antiretroviral therapy program costs in sub\u2013Saharan Africa. J Infect Dis. 2017;215:1362\u20135.","journal-title":"J Infect Dis"},{"key":"9803_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v12070694","volume":"12","author":"NT Parkin","year":"2020","unstructured":"Parkin NT, Avila-Rios S, Bibby DF, Brumme CJ, Eshleman SH, Harrigan PR, et al. Multi-laboratory comparison of next-generation to sanger-based sequencing for HIV-1 drug resistance genotyping. Viruses. 2020;12:1\u201313.","journal-title":"Viruses"},{"key":"9803_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v12121456","volume":"12","author":"C Jennings","year":"2020","unstructured":"Jennings C, Parkin NT, Zaccaro DJ, Capina R, Sandstrom P, Ji H, et al. Application of a sanger-based external quality assurance strategy for the transition of hiv-1 drug resistance assays to next generation sequencing. Viruses. 2020;12:1\u201312.","journal-title":"Viruses"},{"key":"9803_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JCM.00105-18","volume":"56","author":"PL Tzou","year":"2018","unstructured":"Tzou PL, Ariyaratne P, Varghese V, Lee C, Rakhmanaliev E, Villy C, et al. Comparison of an in vitro diagnostic next-generation sequencing assay with sanger sequencing for HIV-1 genotypic resistance testing. J Clin Microbiol. 2018;56:1\u201313.","journal-title":"J Clin Microbiol"},{"key":"9803_CR14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1089\/aid.2013.0258","volume":"30","author":"LPO Coelho","year":"2014","unstructured":"Coelho LPO, Ferreira JL, de Cabral P, de Guimar\u00e3es GB. Brigido LF De M. Genotypic Tropism Prediction from Paired Cell and plasma using single and replicate sequences. AIDS Res Hum Retroviruses. 2014;30:711\u20136.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"9803_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.meegid.2013.04.032","volume":"19","author":"AC Pineda-Pe\u00f1a","year":"2013","unstructured":"Pineda-Pe\u00f1a AC, Faria NR, Imbrechts S, Libin P, Abecasis AB, Deforche K, et al. Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools. Infect Genet Evol. 2013;19:337\u201348.","journal-title":"Infect Genet Evol"},{"key":"9803_CR16","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1093\/nar\/gku739","volume":"42","author":"D Struck","year":"2014","unstructured":"Struck D, Lawyer G, Ternes A-M, Schmit J-C, Bercoff DP. COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification. Nucleic Acids Res. 2014;42:e144\u2013144.","journal-title":"Nucleic Acids Res"},{"key":"9803_CR17","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/bioinformatics\/bty851","volume":"35","author":"PJK Libin","year":"2019","unstructured":"Libin PJK, Deforche K, Abecasis AB, Theys K. VIRULIGN: fast codon-correct alignment and annotation of viral genomes. Bioinformatics. 2019;35:1763\u20135.","journal-title":"Bioinformatics"},{"key":"9803_CR18","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1093\/bioinformatics\/btu531","volume":"30","author":"A Larsson","year":"2014","unstructured":"Larsson A. AliView: a fast and lightweight alignment viewer and editor for large datasets. Bioinformatics. 2014;30:3276\u20138.","journal-title":"Bioinformatics"},{"key":"9803_CR19","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/molbev\/msp077","volume":"26","author":"MN Price","year":"2009","unstructured":"Price MN, Dehal PS, Arkin AP. FastTree: Computing large minimum evolution trees with profiles instead of a Distance Matrix. Mol Biol Evol. 2009;26:1641\u201350.","journal-title":"Mol Biol Evol"},{"issue":"jun18 1","key":"9803_CR20","doi-asserted-by":"publisher","first-page":"e4159","DOI":"10.1136\/bmj.e4159","volume":"344","author":"RL Hamers","year":"2012","unstructured":"Hamers RL, Kityo C, Lange JMA, Wit TFRd, Mugyenyi P. Global threat from drug resistant HIV in sub-saharan Africa. BMJ. 2012;344(jun18 1):e4159\u20134159.","journal-title":"BMJ"},{"key":"9803_CR21","doi-asserted-by":"publisher","first-page":"e1004293","DOI":"10.1371\/journal.pmed.1004293","volume":"20","author":"SC Inzaule","year":"2023","unstructured":"Inzaule SC, Siedner MJ, Little SJ, Avila-Rios S, Ayitewala A, Bosch RJ, et al. Recommendations on data sharing in HIV drug resistance research. PLoS Med. 2023;20:e1004293.","journal-title":"PLoS Med"},{"key":"9803_CR22","doi-asserted-by":"publisher","first-page":"15893","DOI":"10.1038\/s41598-024-66905-1","volume":"14","author":"CS Sebasti\u00e3o","year":"2024","unstructured":"Sebasti\u00e3o CS, Abecasis AB, Jandondo D, Sebasti\u00e3o JMK, Vig\u00e1rio J, Comandante F, et al. HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-na\u00efve adult patients in Luanda, Angola. Sci Rep. 2024;14:15893.","journal-title":"Sci Rep"},{"key":"9803_CR23","doi-asserted-by":"crossref","unstructured":"Sebasti\u00e3o CS, Morais J, Brito M. Clinical and Public Health Implications of HIV-1 Genetic Diversity and Drug Resistance Mutations in Angola: a systematic review. AIDS Rev. 2021;23.","DOI":"10.24875\/AIDSRev.20000057"},{"key":"9803_CR24","doi-asserted-by":"publisher","first-page":"e0225251","DOI":"10.1371\/journal.pone.0225251","volume":"14","author":"CS Sebasti\u00e3o","year":"2019","unstructured":"Sebasti\u00e3o CS, Neto Z, de Jesus CS, Mirandela M, Jandondo D, Couto-Fernandez JC, et al. Genetic diversity and drug resistance of HIV-1 among infected pregnant women newly diagnosed in Luanda, Angola. PLoS ONE. 2019;14:e0225251.","journal-title":"PLoS ONE"},{"key":"9803_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/tropicalmed6010029","volume":"6","author":"CS Sebasti\u00e3o","year":"2021","unstructured":"Sebasti\u00e3o CS, Morais J, Brito M. Factors influencing HIV Drug Resistance among pregnant women in Luanda, Angola: findings from a cross-sectional study. Trop Med Infect Dis. 2021;6:29.","journal-title":"Trop Med Infect Dis"},{"key":"9803_CR26","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1002\/jmv.26148","volume":"92","author":"CS Sebasti\u00e3o","year":"2020","unstructured":"Sebasti\u00e3o CS, Neto Z, Jandondo D, Mirandela M, Morais J, Brito M. HIV, Hepatitis B virus, hepatitis C virus, and syphilis among pregnant women attending antenatal care in Luanda, Angola: Seroprevalence and risk factors. J Med Virol. 2020;92:3265\u201370.","journal-title":"J Med Virol"},{"key":"9803_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003866","author":"P Gon\u00e7alves","year":"2024","unstructured":"Gon\u00e7alves P, Barreto J, Santos M, Leal S, Marcelino J, Abecasis A, et al. HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde, 2019\u20132021. AIDS. 2024. https:\/\/doi.org\/10.1097\/QAD.0000000000003866.","journal-title":"AIDS"},{"key":"9803_CR28","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3390\/v14091992","volume":"14","author":"N Ismael","year":"2022","unstructured":"Ismael N, Wilkinson E, Mahumane I, Gemusse H, Giandhari J, Bauhofer A, et al. Molecular Epidemiology and trends in HIV-1 transmitted Drug Resistance in Mozambique 1999\u20132018. Viruses. 2022;14:1992.","journal-title":"Viruses"},{"key":"9803_CR29","unstructured":"UNAIDS. Country progress report-Sao Tome and Principe Global AIDS Monitoring 2018."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09803-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09803-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09803-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T09:15:24Z","timestamp":1724922924000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09803-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9803"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09803-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research team will ensure data protection according to the Helsinki Declaration. The study protocol was submitted to ethical committees of participating healthcare institutions in Angola, Cape Verde, Mozambique, and Sao Tome & Principe. The study participants will receive written information, including the description and the goals of the study, as well as, information about data privacy procedures. Moreover, informed signed consent will be requested from all participants before they are enrolled in the study. All samples stored will be analysed and destroyed no later than December 31, 2044, following current legal and ethical requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"884"}}